Quotient Clinical Expands Pharmaceutical Sciences Capabilities
The company has doubled its pharmaceutical sciences capacity through the acquisition of a second GMP manufacturing facility and the construction of new formulation development and pharmaceutical analysis laboratories.
Quotient Clinical announced that it has doubled its pharmaceutical sciences capacity through the acquisition of a second GMP manufacturing facility and the construction of new formulation development and pharmaceutical analysis laboratories.
The new laboratories, which are based within the Quotient’s existing Nottingham facility and have a footprint of approximately 8,000 square feet, were built to support increasing demand for the company’s formulation development services.
The new GMP manufacturing facility is located in the MediCity innovation hub in Nottingham, and has a footprint of 3,000 square feet. It comprises eight multipurpose suites, offering the opportunity to manufacture drug products on a large scale, with all the necessary containment controls to enable safe handling of high-potency molecules. The facility is scheduled to become operational later in 2015 following an MHRA inspection.
Source: Quotient
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.
